Creating Asthma Empowerment Collaborations to Reduce Childhood Asthma Disparities (U34)

The summary for the Creating Asthma Empowerment Collaborations to Reduce Childhood Asthma Disparities (U34) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Creating Asthma Empowerment Collaborations to Reduce Childhood Asthma Disparities (U34): The purpose of this FOA is to support investigators planning a clinical trial to evaluate Asthma Care Implementation Programs (ACIP) for chidren at high risk of poor asthma outcomes. Investigators must propose an ACIP for this population that translates research into community practice by integrating interventions with demonstrated efficacy from multiple sectors into a comprehensive program. Each proposed evidence-based intervention within the ACIP must address at least one of the following different sectors that can contribute to a system of care for children: medical care, family, home, and community. During the project period, investigators will conduct a community needs assessment to ensure their proposed ACIP will meet the needs of children at high risk of poor asthma outcomes within their community in the U.S. Therefore, the proposed interventions may be modified based on the community needs assessment. As the interventions included in the ACIP are modified during the U34, the proposed clinical trial to evaluate the ACIP should also be adjusted and developed into a complete protocol. On the basis of the refined interventions from each of the requisite sectors, investigators must also solidify existing relationships or engage appropriate collaborators from each of the sectors who are able to identify resources they can commit to provide for the ACIP. By the conclusion of the U34, applicants should be prepared to apply for a U01 grant, described in RFA-HL-17-001, which will support the clinical trial, assessment of the sustainability of the interventions, and define best practices for implementation of interventions in children at high risk of poor asthma outcomes.
Federal Grant Title: Creating Asthma Empowerment Collaborations to Reduce Childhood Asthma Disparities (U34)
Federal Agency Name: National Institutes of Health
Grant Categories: Health
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-HL-15-028
Type of Funding: Cooperative Agreement
CFDA Numbers: 93.838
CFDA Descriptions: Lung Diseases Research
Current Application Deadline: Feb 20, 2015
Original Application Deadline: Feb 20, 2015
Posted Date: Dec 9, 2014
Creation Date: Dec 9, 2014
Archive Date: Mar 23, 2015
Total Program Funding: $3,000,000
Maximum Federal Grant Award: $225,000
Minimum Federal Grant Award: none
Expected Number of Awards: 9
Cost Sharing or Matching: No
Applicants Eligible for this Grant
Public and State controlled institutions of higher education
City or township governments
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
Small businesses
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
County governments
Public housing authorities/Indian housing authorities
Native American tribal organizations (other than Federally recognized tribal governments)
Native American tribal governments (Federally recognized)
State governments
For profit organizations other than small businesses
Special district governments
Independent school districts
Additional Information on Eligibility
Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Link to Full Grant Announcement
http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-15-028.html
Grant Announcement Contact
NIH OER Webmaster [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

National Institutes of Health 301-496-3405
Similar Government Grants
Single Source: Molecular Atlas of Lung Development Program (LungMAP) Phase 3 - Data Coordi...
Single Source: Molecular Atlas of Lung Development Program (LungMAP) Phase 3 - Human Tissu...
Molecular Atlas of Lung Development Program (LungMAP) Phase 3 - Research Centers (U01 Clin...
Pathogenesis of Sars Lung Disease: in Vitro Studies and Animal Models
Lung Response to Inhaled Highly Toxic Chemicals
Protein Interactions Governing Membrane Transport in Pulmonary Health and Disease (R01)
More Grants from the National Institutes of Health
Feasibility of Novel Diagnostics for TB in Endemic Countries (FEND for TB) (R01 Clinical ...
Specialized Programs of Research Excellence (SPOREs) in Cancer Health Disparities and Mino...
Strategies for Controlled Release of HIV Vaccines (SCORE-H) (R01 Clinical Trial Not Allowe...
NINDS Program Project Grant (P01 Clinical Trial Optional)
Centers for Research in Emerging Infectious Diseases (CREID) Network (U01 Clinical Trial N...

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2024 FederalGrants.com